Since both CD133+ and CD34+ cells have been successfully applied in cell therapies for retinopathy, CD133+CD34+ cells were directly applied in the present study (Kanji et al., 2014; Fadini et al., 2017; Rong et al., 2018). Here, CD34 is linked to retinal disorder.